Hjem › Kreft i gallesystemet › Colorado
Kliniske studier for Kreft i gallesystemet i Colorado
7 studier for Kreft i gallesystemet søker deltakere på steder i Colorado.
Byer i Colorado
Offisiell studietekst (engelsk)
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
- Sarah Cannon Research Institute (SCRI), Denver
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT05482893A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
- Research Site, Aurora
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07221253A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
- University of Colorado Anschutz Medical Campus ( Site 0299), Aurora
- University of Colorado Anschutz Medical Campus ( Site 0325), Aurora
- University of Colorado Anschutz Medical Campus ( Site 0326), Aurora
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06428409AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Avenzo Therapeutics Recruiting Site, Denver
RekruttererFase 1/2
Alder 18 til 75 · Alle kjønn · Oppdatert 4. sep. 2026 · NCT07038343Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection
- University of Colorado Denver, Aurora
- UCHealth Highlands Ranch Hospital, Highlands Ranch
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 18 til 99 · Alle kjønn · Oppdatert 24. aug. 2026 · NCT05517811Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Sarah Cannon Research Institute, Denver
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 6. mai 2026 · NCT06239194Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
- UCHealth Cancer Care - Anschutz Medical Campus, Aurora
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 5. mar. 2026 · NCT04900818Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.